Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in Autism Spectrum Disorder (ASD)

NCT03859336 is registered in ClinicalTrials.gov with Phoenix Children's Hospital as lead sponsor.

NCT NCT03859336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03859336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Frequency Transdermal Neuromodulation to Decrease Anxiety and Improve Sleep in Autism Spectrum Disorder (ASD)
Lead sponsor
Phoenix Children's Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 21, 2019
Completion date
October 6, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder